“DALK is a safe procedure with good, longterm graft survival; that is, 99% after 10 years has been reported in the literature,” said Dr. Sarnicola, a resident in ophthalmology, Siena University, Italy. “The procedure has a low rejection rate with a low risk of secondary complications.” >>Leggi l’articolo completo
Fonte: Highbeam